US 10265412
Enzyme replacement therapy for treating lysosomal storage diseases
granted A61KA61K38/47A61K47/642
Quick answer
US patent 10265412 (Enzyme replacement therapy for treating lysosomal storage diseases) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
- Grant date
- Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/47, A61K47/642, A61P, A61P25/00